The present invention is of a method for reducing activity of inflammatory
immune cells by exposure to selenium. Particularly, the invention relates
to a method of short-term, high dose dietary selenium supplementation for
treating a subject having an inflammatory disease, particularly
inflammatory bowel disease (IBD). An article of manufacture comprising a
pharmaceutical composition providing a therapeutic selenium unit dosage
suitable for the method of the present invention is also provided.